179 related articles for article (PubMed ID: 36765644)
1. Classification of Pancreatic Ductal Adenocarcinoma Using MALDI Mass Spectrometry Imaging Combined with Neural Networks.
Kanter F; Lellmann J; Thiele H; Kalloger S; Schaeffer DF; Wellmann A; Klein O
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765644
[TBL] [Abstract][Full Text] [Related]
2. Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging.
Casadonte R; Kriegsmann M; Perren A; Baretton G; Deininger SO; Kriegsmann K; Welsch T; Pilarsky C; Kriegsmann J
Proteomics Clin Appl; 2019 Jan; 13(1):e1800046. PubMed ID: 30548962
[TBL] [Abstract][Full Text] [Related]
3. MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree.
Bollwein C; Gonҫalves JPL; Utpatel K; Weichert W; Schwamborn K
Molecules; 2022 May; 27(11):. PubMed ID: 35684402
[TBL] [Abstract][Full Text] [Related]
4. MALDI-TOF-MS Analysis in the Discovery and Identification of the Serum Peptide Pattern of Pancreatic Ductal Adenocarcinoma.
Huang Y; Chen F; Zhang L; Lv Q; Yan J; Cui W
Lab Med; 2021 Nov; 52(6):558-566. PubMed ID: 33929035
[TBL] [Abstract][Full Text] [Related]
5. MALDI-MSI: A Powerful Approach to Understand Primary Pancreatic Ductal Adenocarcinoma and Metastases.
Gonçalves JPL; Bollwein C; Schlitter AM; Kriegsmann M; Jacob A; Weichert W; Schwamborn K
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956764
[TBL] [Abstract][Full Text] [Related]
6. Cancer Tissue Classification Using Supervised Machine Learning Applied to MALDI Mass Spectrometry Imaging.
Mittal P; Condina MR; Klingler-Hoffmann M; Kaur G; Oehler MK; Sieber OM; Palmieri M; Kommoss S; Brucker S; McDonnell MD; Hoffmann P
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771551
[TBL] [Abstract][Full Text] [Related]
7. Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging.
Loch FN; Klein O; Beyer K; Klauschen F; Schineis C; Lauscher JC; Margonis GA; Degro CE; Rayya W; Kamphues C
Biology (Basel); 2021 Oct; 10(10):. PubMed ID: 34681132
[TBL] [Abstract][Full Text] [Related]
8. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
9. MALDI-Imaging for Classification of Epithelial Ovarian Cancer Histotypes from a Tissue Microarray Using Machine Learning Methods.
Klein O; Kanter F; Kulbe H; Jank P; Denkert C; Nebrich G; Schmitt WD; Wu Z; Kunze CA; Sehouli J; Darb-Esfahani S; Braicu I; Lellmann J; Thiele H; Taube ET
Proteomics Clin Appl; 2019 Jan; 13(1):e1700181. PubMed ID: 30471200
[TBL] [Abstract][Full Text] [Related]
10. Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma.
Sun N; Trajkovic-Arsic M; Li F; Wu Y; Münch C; Kunzke T; Feuchtinger A; Steiger K; Schlitter AM; Weichert W; Esposito I; Siveke JT; Walch A
EJNMMI Res; 2021 Dec; 11(1):120. PubMed ID: 34851463
[TBL] [Abstract][Full Text] [Related]
11. Accurate classification of Listeria species by MALDI-TOF mass spectrometry incorporating denoising autoencoder and machine learning.
Li Y; Gan Z; Zhou X; Chen Z
J Microbiol Methods; 2022 Jan; 192():106378. PubMed ID: 34818574
[TBL] [Abstract][Full Text] [Related]
12. Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.
Ucal Y; Tokat F; Duren M; Ince U; Ozpinar A
Thyroid; 2019 Aug; 29(8):1125-1137. PubMed ID: 31064269
[No Abstract] [Full Text] [Related]
13. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
Zhao L; Zhao H; Yan H
BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
[TBL] [Abstract][Full Text] [Related]
14. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.
Grüner BM; Hahne H; Mazur PK; Trajkovic-Arsic M; Maier S; Esposito I; Kalideris E; Michalski CW; Kleeff J; Rauser S; Schmid RM; Küster B; Walch A; Siveke JT
PLoS One; 2012; 7(6):e39424. PubMed ID: 22761793
[TBL] [Abstract][Full Text] [Related]
15. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections.
Djidja MC; Claude E; Snel MF; Scriven P; Francese S; Carolan V; Clench MR
J Proteome Res; 2009 Oct; 8(10):4876-84. PubMed ID: 19673544
[TBL] [Abstract][Full Text] [Related]
16. Automatic Pancreatic Ductal Adenocarcinoma Detection in Whole Slide Images Using Deep Convolutional Neural Networks.
Fu H; Mi W; Pan B; Guo Y; Li J; Xu R; Zheng J; Zou C; Zhang T; Liang Z; Zou J; Zou H
Front Oncol; 2021; 11():665929. PubMed ID: 34249702
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous squamous cell carcinoma characterized by MALDI mass spectrometry imaging in combination with machine learning.
Brorsen LF; McKenzie JS; Tullin MF; Bendtsen KMS; Pinto FE; Jensen HE; Haedersdal M; Takats Z; Janfelt C; Lerche CM
Sci Rep; 2024 May; 14(1):11091. PubMed ID: 38750270
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in matrix-assisted laser desorption/ionisation mass spectrometry imaging (MALDI-MSI) for in situ analysis of endogenous molecules in plants.
Qin L; Zhang Y; Liu Y; He H; Han M; Li Y; Zeng M; Wang X
Phytochem Anal; 2018 Jul; 29(4):351-364. PubMed ID: 29667236
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Spatial Peptide Signatures for Neuroblastoma Risk Assessment by MALDI Mass Spectrometry Imaging.
Wu Z; Hundsdoerfer P; Schulte JH; Astrahantseff K; Boral S; Schmelz K; Eggert A; Klein O
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202325
[TBL] [Abstract][Full Text] [Related]
20. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
